Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Genentech Takes Slice Of Novartis' Fovista Rights

This article was originally published in Scrip

Executive Summary

Roche's Genentech subsidiary is to join Novartis in another wet AMD adventure, having decided to exercise its option on Novartis' ex-US rights to Ophthotech Corporation's leading investigational PDGF inhibitor Fovista (pegpleranib).